© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
513740 |
As an accredited 5-Bromo-1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Inside the labs where drug discovery and modern chemical synthesis meet, new compounds often drive progress, and 5-Bromo-1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione steps into that space. In my own experience with medicinal chemistry projects, the excitement and pressure to find unique, effective molecules can define success. This compound brings a structure rich in both functional diversity and practical stability, expanding what’s possible for researchers working with complex molecules.
It seems fair to say that the fine details in a compound’s structure create memorable impacts. The presence of bromine and fluorine atoms, especially when they’re arranged smartly along a pyrimidine ring, offers both selectivity and the kind of reactivity that gets organic chemists talking. Too many times, I’ve seen research grind to a halt because precursor molecules lacked the right functional sites for the next synthetic step. This one, with its bromo and fluoro groups, opens doors many standard pyrimidines keep shut.
Beyond the obvious reactivity, the trifluoromethyl group packed into the benzyl moiety brings more than a mouthful of chemistry lingo. Drawing from my work with CNS-active compounds, I know how these electron-withdrawing groups tend to boost metabolic stability, sometimes shifting how molecules interact with target proteins or cross membranes. This advantage draws attention from both academic and commercial teams chasing lead compounds in pre-clinical pipelines.
A lot of commercially available pyrimidine-based products stick to minimalist formulas. They get the job done for basic templating, but often leave medicinal chemists wishing for more flexibility. Here, methylation at position six boosts lipophilicity—something screening teams target in optimizing drug-like properties. Bromination and multiple fluorinations don’t just fill out a spec sheet, they give chemists solid anchors for cross-coupling, halogenation, and nucleophilic substitutions, the bread-and-butter reactions of most advanced libraries.
Traditional analogs lack this degree of substitution. In hands-on terms, I can remember spending weeks coaxing less-reactive starting materials to behave during Suzuki or Buchwald cross-coupling reactions. Substituents like bromine and trifluoromethyl dramatically improve yields and streamline routes by offering convenient “handles” for further elaboration.
Most chemists running modern drug discovery platforms are searching for partners in heterocycle synthesis and libraries for high-throughput screening. This product doesn’t limit itself to one class of targets. Its functional group arrangement gives medicinal teams the freedom to create analogs for enzyme inhibitors, nucleotide mimics, or even as intermediates for imaging probes. In peptide chemistry, pyrimidines such as these offer unique opportunities for labeling and probing selectivity.
Working on kinase inhibitor projects in the past, I’ve watched teams bet on electron-withdrawing groups to suppress metabolic deactivation while enhancing target affinity. By combining fluorine atoms with a bromine site, this molecule goes beyond the generic templates found in large catalogs. The increased electron density around specific sites often leads to improved target-binding affinity, helping compounds stand out during screening.
On the bench, real differences show up in reaction flasks, not just on paper. Bromine at position five encourages efficient palladium-catalyzed coupling, letting researchers quickly build bigger or more complex molecules. The addition of a benzylic group with both fluorine and trifluoromethyl further widens the chemical window, supporting more ambitious modifications without sacrificing the molecule’s core stability.
Leaving behind less-functionalized derivatives, this compound bridges the needs of basic building block and advanced intermediate. Methyl, fluoro, and bromine substitutions give chemists the chance to branch in multiple directions, creating both small adjustments and sweeping changes to scaffold properties.
Looking back at my years in combinatorial library assembly, I used to reach for stock pyrimidines as safe defaults. These options often limited further expansion due to a lack of orthogonal functionality. Here, we see a sharp difference: the mix of bromo, methyl, and trifluoromethyl groups allows teams to pull this molecule in several innovative directions. By contrast, plain pyrimidine-2,4-dione derivatives tend to dead-end during retrosynthetic analysis.
Some might compare this compound to simple uracil analogs, but the electron-poor character created by multiple fluorines and a benzylic linkage changes both the reactivity and physicochemical profile. This opens the field to new strategies in fragment-based drug design, especially in settings where specific hydrogen bonding and lipophilicity are sought.
Molecular design often makes or breaks those long experiment days. This product’s structure supports robustness in challenging conditions. No one wants to repeat failed syntheses due to poorly defined reactivity. The methyl group at position six helps with solubility in organic solvents—critical for smooth separation and purification steps. Meanwhile, bromine and fluoro presence mean teams can quickly attach new fragments.
With a melting point above ambient temperatures and strong resistance to hydrolysis, stability won’t be a roadblock. Weight and density fall within comfortable handling ranges for most synthetic and analytical work, meaning neither solubility nor recovery complicates day-to-day use.
I care about the sustainability and risk profile of what goes down the drain just as much as any regulatory agency. Fluorinated organics always call for a serious look at waste management protocols. This compound gives the advantage of defined, traceable disposal paths without extreme toxicity hazards many halogenated derivatives often bring. Good lab practice keeps environmental risks minimized, and researchers using this molecule are more likely to manage these streams correctly due to its rational, well-documented makeup.
Since this product isn’t highly volatile, accidental exposure risks remain low during careful laboratory handling. Gloves and fume hoods—standard gear by any experienced chemist’s standards—give strong protection during weighing and dissolving. Compared to more reactive halogenated pyrimidines, spills and dust generation are less troublesome in routine operations.
In lab meetings, successful teams always share firsthand stories about what worked and what went wrong. My colleagues in lead optimization programs often point to the bottlenecks: molecules that proved difficult to derivatize or lost activity once the core was altered. The special functional group arrangement on this pyrimidine helps solve that problem. Researchers can use cross-coupling, nucleophilic substitution, and mild reduction conditions—covering the three most popular reaction families in modern lab workflows.
Screening libraries also benefit from molecules designed with diversity in mind. Instead of being forced into a single route, teams can split their synthetic efforts at multiple points, quickly diversifying compound collections. This creates more opportunities for hit finding, which drives competition and innovation between medicinal chemistry teams.
Products often fail not because of core chemistry, but because teams trip over uncertainties about handling or allowable conditions. This compound’s well-characterized structure, combined with clear literature precedent, makes onboarding faster for new research assistants and streamlines method transfers between collaborating labs. Years ago, when training in a high-throughput environment, I saw how unreliable or poorly understood intermediates could slow the whole research machine. Here, researchers benefit from readily available peer-reviewed methods for derivatization and reaction optimization.
Detailed analytical techniques—NMR, LC-MS, and elemental analysis—support full verification for every delivered batch. This reassures both the primary investigators and the production chemists, cutting down risk and making regulatory sign-off or publication go smoother.
The pharmaceutical landscape keeps moving toward more precise, target-driven screens. Compounds that combine both electron-rich and electron-poor centers provide the best launching points for next-generation inhibitors or probes. In projects I’ve followed on both sides of the Atlantic, teams using multifunctional pyrimidines reported quicker SAR cycles and cleaner routes to patentable analogs.
Working under tight deadlines, the difference between a flexible intermediate and one that limits reactivity is night and day. This pyrimidine’s unique group pattern supports rapid customization within nearly any lead program, including antivirals, kinase inhibitors, and diagnostics agents. Access to ready-to-couple handles means less time troubleshooting and more time testing real biological impact.
Whether the project goal is a better PET imaging agent or a more resilient antiviral core, chemists benefit from compounds strong enough to handle both scale and scope. Many university labs face budget and time constraints. Streamlined reagents with robust, predictable chemistry—like this molecule—help teams push projects forward without bottlenecks caused by weak or unresponsive intermediates.
Industrial chemists spend less time troubleshooting difficult reactions or purifications when they pick compounds with built-in flexibility. This pyrimidine derivative, with its triple modification, stands up to the challenge of iterative synthesis, scale-up, and patent circumvention in high-stakes settings.
Much of what happens inside a research lab depends on the quality and creativity present in the inventory. I remember a period when progress in fragment-based drug design stuck simply because supplier catalogs lacked advanced, highly substituted heterocycles. Waiting for months just for an order to arrive, only to discover marginal improvement in synthetic utility, leaves a lasting impression.
Offering both well-documented reactivity and practical handling, this molecule sits at a sweet spot between foundational building block and advanced research tool. It represents a response to unmet needs—driving efficiency and success by letting teams step past the old barriers of generic chemistry.
Talk with any experienced chemist, and you’ll hear that ambition often gets stuck at the level of what’s possible with what’s on hand. By letting research teams run multi-step syntheses without backtracking or redesign, this compound expands the canvas for both incremental and breakthrough innovations.
As peer-reviewed studies spread detailing its applications in everything from kinase research to labeling programs, more chemists see firsthand why pushing beyond standard pyrimidine derivatives pays off in both the short and long term. The enhanced chemical handles improve turnaround times, while the selection of functional groups helps teams sail past common stumbling blocks in both synthesis and purification.
Open forums and collaborative platforms now support a level of transparency and dialogue unthinkable a decade ago. When researchers post about reactions using this specific pyrimidine, others quickly adapt conditions or troubleshoot failures with in-depth commentary. Sharing successful couplings, yield data, and failure analyses in publicly accessible journals or databases brings real, crowd-sourced value that raises everyone’s game.
Having used message boards and collaborative note files during a few crunch times in my own projects, I appreciate reagents that benefit from community insight. Having one more molecule in widespread use, well-documented and peer-reviewed, closes the information gap. That means faster progress and less wasted effort.
The days of buying mystery compounds with weak spectra or ambiguous provenance should be behind us. Researchers expect guarantees that match both label claims and real-world performance. A compound like this benefits from thorough characterization, published synthetic methods, and community feedback. Over time, this track record cements trust between supplier and user.
I’ve preferred buying chemicals from sources committed to transparency, detailed batch records, and readiness to share negative data. Here, the product benefits from this era of accountability, reinforcing a bond that’s worth more than a simple barcode or shipment.
Some of the most celebrated new drugs and diagnostic reagents trace their roots to overlooked chemistry. This pyrimidine, armed with distinctive functional groups and resilient design, serves as a node in the ever-growing network of molecular building blocks. New cycles of modification and evaluation can draw from this product’s strengths even in programs yet to be envisioned.
Wider acceptance and application encourage innovation not just in pharmaceutical pipelines, but in academic basic science, molecular probe design, and even agricultural research. Every added branch on the molecular scaffold means a broader reach for future research, keeping options open as new questions and targets appear on the scientific horizon.
Research doesn’t slow down, and the need for sharper, more flexible reagents only grows. 5-Bromo-1-(2-Fluoro-6-Trifluoromethyl-Benzyl)-6-Methyl-1H-Pyrimidine-2,4-Dione puts in scientists’ hands one more piece of the puzzle—engineered with intent and validated by a growing record of success. From initial screens to the final steps before scale-up, reliable chemistry supports the breakthrough moments every team chases.
Better building blocks bring better results, and the future of molecular medicine, imaging, and beyond will be shaped by compounds that deliver more reactions, more stability, and more opportunity. Researchers who recognize the value in each extra functional handle, each shift in reactivity or physical property, gain advantages that compound over time—not just in papers or patents, but in the real difference their discoveries make.
